Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SILO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSilo Pharma executes 1-for-15 reverse stock split, reducing shares to 1.1M from 16.3M
Filed June 1, 2026 · Period ending June 1, 2026 · ~1 min read
Key Changes
-
high
Every 15 shares will consolidate into 1 share effective 4:01 p.m. ET on June 2, 2026, with post-split trading beginning June 3. Fractional shares will be rounded up to the next whole share.
Item 5.03 view on EDGAR → -
high
Outstanding common shares will decrease from approximately 16.267 million to approximately 1.084 million. The stock will continue trading under ticker symbol SILO on Nasdaq.
Item 5.03 view on EDGAR → -
medium
Authorized common stock will be proportionately reduced to 6,666,667 shares, maintaining the same ratio of authorized-to-outstanding shares as before the split.
Item 5.03 view on EDGAR → -
medium
All outstanding equity awards, warrants, and equity incentive plans will be adjusted proportionately, with share counts reduced by 15-to-1 and exercise prices increased to maintain aggregate value.
Item 5.03 view on EDGAR → -
low
The company's common stock will receive a new CUSIP identifier (82711P 300) following the reverse split to distinguish post-split shares.
Item 5.03 view on EDGAR →
Summary
Silo Pharma is implementing a 1-for-15 reverse stock split effective June 2, 2026, consolidating every 15 existing shares into a single share. This reduces the outstanding share count from approximately 16.3 million to 1.1 million shares. Reverse splits are typically executed to boost per-share stock price, often to maintain compliance with exchange listing requirements or improve institutional investor appeal.
The company is proportionately reducing authorized shares to 6.7 million, which prevents dilution of ownership percentages. For existing shareholders, this is primarily a cosmetic change—your ownership percentage remains the same, though you'll hold fewer shares at a proportionately higher price. All equity awards and warrants will be adjusted to maintain their economic value.
Watch the stock's trading behavior when it begins trading on a post-split basis June 3. If the price doesn't hold at roughly 15 times the pre-split price, it may signal underlying weakness or selling pressure that the reverse split was intended to mask.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · view on EDGAR → · paraphrased
the Company will effect a 1-for-15 reverse split of its issued and outstanding common stock with a concurrent proportionate reduction of its authorized common stock effective as of 4:01 p.m. Eastern Time on June 2, 2026
The company is implementing a 1-for-15 reverse stock split, meaning every 15 shares will be consolidated into 1 share. This takes effect at 4:01 p.m. ET on June 2, 2026, and trading on the post-split basis begins June 3, 2026. The stock will continue trading under the symbol SILO on Nasdaq.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify